通过转录延长变化的遗传性血癌倾向
Jiawei Zhao1, Liam D Cato2, Uma P Arora2
1Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Center for Cancer Immunology, Faculty of Pharmaceutical Sciences, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (CAS), Shenzhen, China.
通过破坏转录延长,CTR9的遗传基因变异显著增加了髓状瘤的风险. 这一发现揭示了血液癌症发展的新机制,
科学领域:
- 遗传学
- 分子生物学
- 癌症学
背景情况:
- 骨髓性恶性瘤中体质突变的定义很好,但遗传性遗传因素在很大程度上是未知的.
- 了解遗传倾向对于全面了解血液癌症病因至关重要.
研究的目的:
- 识别导致个体患有骨髓瘤的遗传基因.
- 阐明已确定的风险变体的功能后果.
主要方法:
- 在大量人群中进行罕见变异关联研究.
- 功能性研究评估CTR9变体对造血干细胞 (HSC) 和转录调节的影响.
主要成果:
- 确定了PAF1转录延长综合体的CTR9作为骨髓瘤恶性倾向的重要基因.
- 证明功能丧失的CTR9变种增加了约10倍的风险.
- 显示部分CTR9功能丧失通过增强的超延长复合体活动扩展HSC,从而调节HSC自我更新调节器.
结论:
- 在骨髓癌的背景下发现了PAF1和超延长复合体之间的新对抗相互作用.
- 确立了CTR9遗传变异,HSC扩张和血液癌症风险之间的联系.
- 提供了可能导致针对性血液癌症预防策略的见解.
更多相关视频
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
相关概念视频
Epigenetic Regulation
X-chromosome...
General Transcription Factors
Cancer Prevention
Some...
Transcription Factors
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
